Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
The Metro Independent Business Alliance, a Twin Cities force for business owners, couldn’t survive bottom-line pressures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback